Carol H. Wysham

1 month ago | medscape.com | Carol H. Wysham |Scott Isaacs

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Carol H. Wysham, MD: Hello. I'm Dr Carol Wysham. Welcome to season three of the Medscape InDiscussion: Type 2 Diabetes podcast series. Today, we'll discuss incorporating screening and management of metabolic dysfunction–associated fatty liver disease in endocrine practice. First, let me introduce my guest, Dr Isaacs.

Oct 31, 2024 | healio.com | Richard Smith |Carol H. Wysham

You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways: The Freestyle Libre 2 and 3 CGM sensors are now approved to be worn during imaging procedures. A system integrating the Freestyle Libre 3 with an automated insulin delivery system has been launched.

Sep 10, 2024 | healio.com | Michael Monostra |Erik Swain |Carol H. Wysham |Richard M. Bergenstal

You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways: Insulin efsitora alfa conferred noninferior HbA1c reductions vs. insulin degludec in two phase 3 trials.

Jul 20, 2023 | consultant360.com | Carol H. Wysham

Conference Coverage In this video, Carol Wysham, MD, provides an overview of the session "Diabetes and Liver Disease: Exploring the Intersections and Best Practices," at our Practical Updates in Primary Care 2023 Virtual Series, including the definition of non-alcoholic fatty liver disease (NAFLD), non-alcoholic fatty liver (NAFL), and non-alcoholic steatohepatitis (NASH), identifying risk factors and diagnostic tools for NAFLD, screening patients for type 2 diabetes, and more.

Jul 14, 2023 | consultant360.com | Carol H. Wysham

Conference Coverage In this video, Carol Wysham, MD, provides a preview of the session "Diabetes and Liver Disease: Exploring the Intersections and Best Practices," at our Practical Updates in Primary Care 2023 Virtual Series, including how people with non-alcoholic fatty liver disease and diabetes present, screening tests, and how to utilize lifestyle changes and bariatric surgery in the management of patients with comorbid fatty liver disease and diabetes, and more.